Patents by Inventor Brigitte Schlegel

Brigitte Schlegel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating neurological conditions and inducing immunosuppression with cephaibols
    Patent number: 7041649
    Abstract: Embodiments of the present invention relate to administering cephaibols to treat conditions of the nervous system and to treat those conditions in which suppressing the immune system would have beneficial effect.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: May 9, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Mathias Schiell, Laszio Vertesy, Joachim Wink, Brigitte Schlegel, Albert Haertl, Udo Graefe
  • Method for treating neurological conditions and inducing immunosuppression with cephaibols
    Publication number: 20040023886
    Abstract: Embodiments of the present invention relate to administering cephaibols to treat conditions of the nervous system and to treat those conditions in which suppressing the immune system would have beneficial effect.
    Type: Application
    Filed: May 21, 2003
    Publication date: February 5, 2004
    Applicant: Aventis Pharma Deutschland Gmbh
    Inventors: Mathias Schiell, Laszio Vertesy, Joachim Wink, Brigitte Schlegel, Albert Haertl, Udo Graefe
  • Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof
    Patent number: 5432157
    Abstract: The invention relates to the chrysospermin active peptides of the formula IAcPhe-Aib-Ser-Aib-x-Leu-Gln-Gly-Aib-Aib-Ala-Ala-Aib-Pro- y-Aib-Aib-Gln-Trp-ol (SEQ ID NO. 1)in which x and y, independently of each other, denote Aib or Iva, which are synthesized by the fungus Apiocrea chrysosperma during fermentation and which accumulate in the culture broth, to a preparation process, to the use of the chrysospermins as pharmacological active compounds, in particular as active compounds against bacteria, fungi and/or nematodes, and for the treatment of rejection reactions in organ transplantations and of tumor disorders, and to the microorganism Apiocrea chrysosperma DSM 7444.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: July 11, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Jorg Metzger, Brigitte Schlegel, Werner F. Fleck, Klausjurgen Dornberger, Wolfgang Ihn, Wolfgang Schade, Udo J. Grafe
  • 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same
    Patent number: 5162533
    Abstract: A 3-cyano-5,4'-bipyridine-1'-oxide of the formula ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R is an amino, alkoxy, oxyalkoxy or chloro residue, have heart stimulating cardiotonic and vasodiolatory properties. They can be preparaed by (a) converting an R-substituted-3-cyano-bipyridine to its corresponding N-oxide, or (b) by substituting an R-residue or an R-unsubstituted precursor of the conpound of fomula (i), and if required, converting the product into its pharmaceutically acceptable acid addition salt.
    Type: Grant
    Filed: March 7, 1991
    Date of Patent: November 10, 1992
    Assignee: Arzneimittelwerk Dresden G.m.b.H.
    Inventors: Erhard Klauschenz, Volker Hagen, Angela Hagen, Peter Muschick, Brigitte Schlegel, Sabine Heer, Gottfried Faust, Hans-Joachim Jansch